BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bordeaux Neurocampus - ECPv4.9.10//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bordeaux Neurocampus
X-ORIGINAL-URL:https://www.bordeaux-neurocampus.fr/en/
X-WR-CALDESC:Events for Bordeaux Neurocampus
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20190930T140000
DTEND;TZID=Europe/Paris:20190930T140000
DTSTAMP:20260426T204901
CREATED:20190708T113929Z
LAST-MODIFIED:20190911T135123Z
UID:109380-1569852000-1569852000@www.bordeaux-neurocampus.fr
SUMMARY:Thesis defense - Marie-Laure Arotcarena
DESCRIPTION:\n	\n		\n			Venue: Centre Broca Nouvelle-Aquitaine / Salle de conférence \n\nMarie-Laure Arotcarena\nIMN – Pathophysiology of parkinsonian syndromes \nThesis supervisor : Benjamin Dehay \n\n		\n	\n”Summary”\n\n	\n		\n			My thesis project was dedicated to the study of synucleinopathies. Synucleinopathies are neurodegenerative diseases characterized by the presence of a-synuclein positive intracytoplasmic inclusions which are present either in neurons for Parkinson’s disease (i.e. Lewy Bodies) or in oligodendrocytes for Multiple system atrophy (i.e. Glial Cytoplasmic Inclusions). The aim of my work was to establish a multifactorial and translational approach through modeling\, mechanistic and therapeutic aspects associated with synucleinopathies. First\, we focused on dissecting the underlying a-synuclein-mediated mechanisms of neurodegeneration using a non-human primate model of Parkinson’s disease. We confirmed the toxic role of a-synuclein in the pathology and highlighted unpredictable cellular processes involved in neurodegeneration. Using the same Parkinson’s disease model\, we studied the hypothesis of a pathological propagation between the central and peripheric nervous systems in an attempt to decipher the initiation point and the direction of propagation of the associated pathology. We thus demonstrated a bidirectional route of propagation of α-synuclein between the CNS and the ENS and within the ENS. Finally\, we focused on the restoration of the autophagic function as a potential common therapeutic target for all synucleinopathies. We demonstrated through a gene-based restoration of the autophagy\, we efficiently reestablish a-synuclein physiological protein levels\, while inducing neuroprotection in a Parkinson’s disease and Multiple system atrophy rodent models. Thus\, this work corroborates the key role of a-synuclein in the etiology of synucleinopathy and offers new common therapeutic strategies for all synucleinopathies to decrease a-synuclein-induced toxicity into the central nervous system. \n\n		\n	\n”Publications”\n\n	\n		\n			En révision : \nArotcarena\, M.L; Dovero\, S; Prigent\, A; Bourdenx\, M; and al.\, Bidirectional gut-to-brain and brain-to-gut propagation of α-synuclein pathology in non-human primates. 1st co-author. \nBourdenx\, M; Nioche\, A; Dovero\, S; Arotcarena M.L and al.\, Machine learning reveals different pathological signatures of patient-derived α-synuclein extracts in non-human primates. 1st co-author. \nPublié : \nArotcarena\, M.-L. Bourdenx\, M. et al. Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathies. JCI Insight. 2019;4(16):e129719. https://doi.org/10.1172/jci.insight.129719 \nArotcarena\, M.L and B. Dehay\, Les synucléinopathies sont-elles des maladies à prions ? Pratique Neurologique FMC (2018)\, 2018. https://doi.org/10.1016/j.praneu.2018.02.006 \nArotcarena ML\, Teil M\, Dehay B (2019) Autophagy in Synucleinopathy: The Overwhelmed and Defective Machinery. Cells (2019)\, 8(6)\, 565; https://doi.org/10.3390/cells8060565 \n\n		\n	\n”Jury”\n\n	\n		\n			Nadine Camougrand (DR2\, CNRS) – IBGC – Bordeaux (Présidente du jury) \nOlga Corti (DR2\, INSERM) – Institut du cerveau et de la Moelle épinière (ICM)\, Paris (Rapporteur) \nPhilippe Hantraye (DR1\, CNRS) – Institut de Biologie François Jacob\, MIRCen\, CEA\, Paris-Saclay (Rapporteur) \n\n		\n	\n\n
URL:https://www.bordeaux-neurocampus.fr/en/event/thesis-defense-marie-laure-arotcarena/
CATEGORIES:Thesis
END:VEVENT
END:VCALENDAR